Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Bayer pledges to go it alone for now, plays down drag from Asian crisis

Article Abstract:

Bayer AG, a Germany-based chemicals and pharmaceuticals firm, intends to remain independent and considers acquisitions in Asia. Bayer, which said it will not acquire Hoechst AG in the near future, contradicts speculations that Bayer with Hoffman La Roche Inc. of Switzerland is contemplating to acquire Hoechst, of which pharmaceutical business will be divided between the two acquirers. Bayer chairman Manfred Schneider said the firm will only buy a pharmaceutical firm if it will remain in the dominant figure among the two firms. Schneider said Bayer is considering acquisitions and deals in Asia and that the financial crisis in Asia will be overcompensated with the economic growth in Europe.

Comment:

Intends to remain independent & considers acquisitions in Asia

Author: Harnischfeger, Uta
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1998
Strategy & planning, Bayer AG

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


BASF reports profit growth but fears stay

Article Abstract:

BASF AG of Germany reported a 15% increase in pre-tax profit in the second-quarter of 1998 to 1.50 billion marks from 1.30 billion marks while group sales fell to 14.3 billion marks from 14.4 billion marks. The company attributed the decrease in sales to declining demand in Asia because of the financial crisis in the region which has affected the chemical industry in Germany. BASF cautioned that it expects its earnings growth to stay flat during the remaining period of 1998. BASF is the hardest hit by the Asian crisis among the three major chemical manufacturers in Germany that also includes Bayer AG and Hoeschst AG.

Comment:

Reports a 15% increase in pre-tax profit in the 2nd-quarter of 1998 to 1.50 bil marks from 1.30 bil marks

Author: Harnischfeger, Uta
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1998

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


BASF posts rise in profit but warns of difficult '99

Article Abstract:

BASF AG of Germany posted a 12% improvement in pretax profit to 1.49 billion marks in the third quarter 1998, compared to 1.33 billion marks in the year-ago period, but warns that 1999 results will not be promising due to the current problematic global economic situation. The company said that the increase was only due to fluctuations in one-time gains and charges. Although it expects to gain a slight increase in full-year pretax profit, a prevailing depressed economy would result in pretax profit that is lower than in the earlier year.

Comment:

Posts 12% improvement in pretax profit to 1.49 bil marks in 3rd quarter 1998, but warns that 1999 results will not be promising

Author: Moore, Stephen
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1998

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Germany, Chemicals, Article, BASF AG
Similar abstracts:
  • Abstracts: Hamburger craze bites Hong Kong. Fees to go? McDonald's pays in order to stay in Beijing. Hamburger craze bites Hong Kong: Snoopy figurines land McDonald's in a consumer dogfight
  • Abstracts: Baan hopes to cut costs in pact with Microsoft. ASML expects weaker results for '98 on tough chip market, Asian crisis
  • Abstracts: SAP likely to meet profit goal. SAP says net fell 7% on strategy errors
  • Abstracts: Hoechst reduces profit expectations. Degussa shares drop 4.2% on filing of Holocaust suit
  • Abstracts: Sweet dreams. FT plans German version
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.